[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 20, 2011 NF ENERGY SAVING CORPORATION Delaware 000-50155 02-0563302 (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Room 3105, Block C, 390 Qingnian Avenue Heping District Shenyang, P.R. China 11000221 (Zip Code) (8624) 2560-9750 (Former Name or Former Address, if Changed Since Last Report) see]
[Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to yourorporation of our audit reportted December 23, 2011 relating to the audited financial statements of Shaanxi Weinan Aoxing Pharmaceuticals, of and for the year ended December 31, 2010 in Form 8-K/A of Biostar Pharmaceuticals,] [Shaanxi Weinan Aoxing Pharmaceuticals, (formerly Shaanxi Weinan Huaren Pharmaceuticals,) Index to Financial Statements Year ended December 31, 2010 Page F-1 Balance Sheet F-2 Statement of Operations F-3 Statement of Stockholders Equity F-4 Statement ofsh Flows F-5 Notes to Financial Statements F-6 to F-16 To the Board of Directors] [UNAUDITED PRO FORMANDENSEDMBINED FINANCIAL STATEMENTS On October 11, 2011, Biostar Pharmaceuticals, (NASDAQ GM: BSPM) (Biostar or thempany), through its wholly owned variable interest entity, Shaanxi Aoxing Pharmaceutical acquired 100% equity interest (the Acquisition) of Shaanxi Weinan Aoxing Pharmaceutical, (formerly Shaanxi Weinan Huaren Pharmaceutical,) (Shaanxi Weinan) at ash purchasensideration of RMB61 million (approximately $9.5 million).]
[Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to yourorporation of our audit reportted December 23, 2011 relating to the audited financial statements of Shaanxi Weinan Aoxing Pharmaceuticals, of and for the year ended December 31, 2010 in Form 8-K/A of Biostar Pharmaceuticals,] [Shaanxi Weinan Aoxing Pharmaceuticals, (formerly Shaanxi Weinan Huaren Pharmaceuticals,) Index to Financial Statements Year ended December 31, 2010 Page F-1 Balance Sheet F-2 Statement of Operations F-3 Statement of Stockholders Equity F-4 Statement ofsh Flows F-5 Notes to Financial Statements F-6 to F-16 To the Board of Directors] [UNAUDITED PRO FORMANDENSEDMBINED FINANCIAL STATEMENTS On October 11, 2011, Biostar Pharmaceuticals, (NASDAQ GM: BSPM) (Biostar or thempany), through its wholly owned variable interest entity, Shaanxi Aoxing Pharmaceutical acquired 100% equity interest (the Acquisition) of Shaanxi Weinan Aoxing Pharmaceutical, (formerly Shaanxi Weinan Huaren Pharmaceutical,) (Shaanxi Weinan) at ash purchasensideration of RMB61 million (approximately $9.5 million).]
[FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported):December 20, 2011 NF ENERGYVINGRPORATION Delaware 000-50155 02-0563302 (State or Other Jurisdiction oforporation) (IRS Employer Identification No.) Room 3105, Block C, 390 Qingnian Avenue Heping District Shenyang, P.R. China 11000221 (Zipde) (8624) 2560-9750 (Former Name or Formerdress, if Changed Since Last Report)]
[CCG Investor Relations Crocker Coulson, President Tel: +1-646-213-1915 crocker.coulson@ccgir.com Email: Orient Paper, Inc. Winston Yen, CFO Phone: +1-562-818-3817 info@orientpaperinc.com Email: Orient Paper Announces Production Launch and Video Release of New Corrugating Medium Paper Line BAODING, Hebei, China – December 23, 2011 Orient Paper, Inc. Click here to view the video. Orient Paper’s new video reviews the Company’s recently constructed corrugating] [Item 8.01 Other Events.]
[FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported):December 20, 2011 NF ENERGYVINGRPORATION Delaware 000-50155 02-0563302 (State or Other Jurisdiction oforporation) (IRS Employer Identification No.) Room 3105, Block C, 390 Qingnian Avenue Heping District Shenyang, P.R. China 11000221 (Zipde) (8624) 2560-9750 (Former Name or Formerdress, if Changed Since Last Report)]
